Analyst Consensus ?
ConsensusHold22 ratings
Bullish836.4%
Neutral1463.6%
Bearish00.0%
Everest Group, Ltd. · EG · FY2026 Q3 · Calendar Q4 2026
Everest pairs strong earnings with heavier reserve protection
Everest’s Q3 showed earnings resilience from underwriting discipline and investment income, but the quarter also highlighted softer premiums, reserve conservatism, and competitive market conditions.
Reported After market closeNYSEFinancial Services
$15.36B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$7.62
Consensus $9.38
EPS surprise
-18.8%
Reported versus consensus
Reported revenue
$3.71B
Consensus $3.81B
Revenue surprise
-2.6%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+3.5%
Event window
SPY move
-0.4%
Same window
Abnormal move
+3.9%
Stock minus SPY
Volume
4.9×
Versus trailing sessions
Subsequent drift
+2.0%
Up to 20 sessions
EGSPY benchmark
Ask FN2 about EG FY2026 Q3
Transcript, numbers and history already loaded
Why did EG rise 3.5% after missing EPS estimates in FY2026 Q3?What changed in EG's guidance and outlook in FY2026 Q3?Give me the bull and bear case for EG after FY2026 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Reserve margin over the actuarial central estimate rose above $850 million, while capital returns accelerated to $550 million in the quarter. Gross written premium declined about 4% year over year, and the AIG TSA payment ended in Q3.
Guidance delta
Management maintained a selective underwriting approach and the $300 million quarterly share-repurchase floor; no numerical guidance change was provided.
Key takeaways
- Operating EPS was supported by disciplined underwriting and record net investment income despite lower gross written premium.
- Management increased reserve protection, particularly in casualty reinsurance, while continuing to target specialty and financial-line growth.
- Capital returns reached $550 million in the quarter, with management retaining its quarterly repurchase floor.
Management priorities
- Maintain disciplined, selective underwriting in specialty and financial lines.
- Continue the reserve study process, including additional lines in Q4.
- Deploy capital toward high-margin international specialty opportunities while managing the AIG transition.
Follow EG with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$410.8Current
$332Low
$395.6Average
$485High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 30, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 7, 2026 |
| TD Cowen | Hold | Hold | Maintain | Aug 19, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 3, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 30, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 6, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | May 14, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 14, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Oct 29, 2025 |
| Raymond James | Outperform | Strong Buy | Downgrade | Sep 22, 2025 |
| Jefferies | Buy | Hold | Upgrade | Apr 11, 2025 |
| Deutsche Bank | Buy | Hold | Upgrade | Mar 28, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Nov 9, 2020 |
| CFRA | Hold | Hold | Maintain | Feb 11, 2020 |
| Goldman Sachs | Neutral | Sell | Upgrade | Nov 14, 2016 |
| Sidoti & Co. | Buy | Neutral | Upgrade | May 22, 2013 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 14, 2013 |
| JP Morgan | Overweight | Neutral | Upgrade | Dec 19, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $410.8. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $398 | $366.84 | -3.1% | Oct 7, 2026 |
| RBC Capital | Analyst unavailable | $455 | $369.42 | +10.8% | Sep 22, 2026 |
| Rosenblatt Securities | Analyst unavailable | $455 | $369.42 | +10.8% | Sep 22, 2026 |
| UBS | Brian Meredith | $395 | $377.12 | -3.8% | Aug 3, 2026 |
| Mizuho Securities | Yaron Kinar | $416 | $375.36 | +1.3% | Jul 31, 2026 |
| Evercore ISI | Analyst unavailable | $377 | $377.19 | -8.2% | Jul 30, 2026 |
| Atlantic Equities | Analyst unavailable | $484 | $364.88 | +17.8% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $375 | $371.62 | -8.7% | Jul 10, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $390 | $371.29 | -5.1% | Jul 9, 2026 |
| Mizuho Securities | Yaron Kinar | $418 | $371.29 | +1.8% | Jul 9, 2026 |
| Barclays | Analyst unavailable | $420 | $372.93 | +2.2% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $360 | $371.35 | -12.4% | Jul 6, 2026 |
| UBS | Analyst unavailable | $355 | $358.42 | -13.6% | May 21, 2026 |
| BMO Capital | Michael Zaremski | $376 | $347.97 | -8.5% | May 14, 2026 |
| Morgan Stanley | Bob Huang | $340 | $351.54 | -17.2% | May 7, 2026 |
| UBS | Analyst unavailable | $374 | $351.26 | -9.0% | May 4, 2026 |
| Mizuho Securities | Analyst unavailable | $365 | $333.52 | -11.1% | Apr 13, 2026 |
| Mizuho Securities | Yaron Kinar | $360 | $330.76 | -12.4% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $358 | $319.92 | -12.9% | Jan 14, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $344 | $319.92 | -16.3% | Jan 14, 2026 |
| Wells Fargo | Elyse Greenspan | $332 | $328.38 | -19.2% | Jan 13, 2026 |
| UBS | Brian Meredith | $345 | $329.1 | -16.0% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $377 | $331.43 | -8.2% | Jan 8, 2026 |
| Evercore ISI | Analyst unavailable | $365 | $330.88 | -11.1% | Jan 7, 2026 |
| Mizuho Securities | Analyst unavailable | $359 | $328.56 | -12.6% | Dec 15, 2025 |
| Raymond James | Gregory Peters | $350 | $314.52 | -14.8% | Nov 3, 2025 |
| Barclays | Analyst unavailable | $365 | $314.7 | -11.1% | Oct 31, 2025 |
| Barclays | Analyst unavailable | $425 | $343.98 | +3.5% | Oct 28, 2025 |
| Barclays | Alex Scott | $430 | $364.86 | +4.7% | Oct 8, 2025 |
| Evercore ISI | Analyst unavailable | $384 | $353.13 | -6.5% | Oct 1, 2025 |
| Raymond James | Gregory Peters | $375 | $335.38 | -8.7% | Sep 22, 2025 |
| Wells Fargo | Elyse Greenspan | $371 | $326.04 | -9.7% | Aug 4, 2025 |
| Wells Fargo | Elyse Greenspan | $362 | $340.45 | -11.9% | Jul 10, 2025 |
| Barclays | Alex Scott | $470 | $341.72 | +14.4% | Feb 4, 2025 |
| BMO Capital | Michael Zaremski | $453 | $353.52 | +10.3% | Jan 10, 2025 |
| BMO Capital | Michael Zaremski | $372 | $368.43 | -9.4% | Nov 14, 2024 |
| Bank of America Securities | Joshua Shanker | $485 | $388.89 | +18.1% | Oct 10, 2024 |
| Barclays | Alex Scott | $527 | $392.5 | +28.3% | Sep 4, 2024 |
| BMO Capital | Michael Zaremski | $403 | $360.63 | -1.9% | Aug 7, 2024 |
| Raymond James | Analyst unavailable | $385 | $356.33 | -6.3% | Feb 2, 2023 |
| Wells Fargo | Analyst unavailable | $365 | $332.95 | -11.1% | Nov 29, 2022 |
| Morgan Stanley | Analyst unavailable | $345 | $325.32 | -16.0% | Nov 22, 2022 |
| Jefferies | Analyst unavailable | $344 | $280.12 | -16.3% | Jul 12, 2022 |
Track every rating change on EG the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationEverest Group, Ltd., together with subsidiaries, provides reinsurance and insurance products in the United States, Europe, and internationally. It operates in two segment, Insurance and Reinsurance. The company writes property and casualty reinsurance; treaty and facultative reinsurance products; and specialty lines of business through reinsurance brokers, as well as directly with ceding companies; and writes property and casualty insurance directly, as well as through brokers, surplus lines, and general agents. It provides reinsurance products comprising mortgage, catastrophe, marine, aviation, engineering, professional line, credit and surety, motor, agriculture/crop, and political violence reinsurance products. In addition, the company offers commercial property and casualty insurance products through wholesale and retail brokers, surplus lines brokers, and program administrators. The company was formerly known as Everest Re Group, Ltd. and changed its name to Everest Group, Ltd. in July 2023.Everest Group, Ltd., was founded in 1973 and is headquartered in Hamilton, Bermuda.
Historical context
All EG earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| NWG NatWest Group plc | FY2026 Q3 · Calendar Q4 2026 | — | -9.1% | NatWest keeps guidance as deposits and wealth management expand |
| RKT Rocket Companies, Inc. | FY2026 Q3 · Calendar Q4 2026 | +10.8% | +5.0% | Rocket Companies: AI and servicing support resilience as Q4 outlook softens |
| MA Mastercard Incorporated | FY2026 Q3 · Calendar Q4 2026 | +2.7% | +4.2% | Mastercard Q3 growth accelerates as services and digital payments expand |
| MKL Markel Corporation | FY2026 Q3 · Calendar Q4 2026 | -2.3% | +1.2% | Markel posts strong Q3 as underwriting and industrial results improve |
| OWL Blue Owl Capital Inc. | FY2026 Q3 · Calendar Q4 2026 | +6.6% | +7.7% | Blue Owl reports strong Q3 growth as fundraising and fee income rise |
| KB KB Financial Group Inc. | FY2026 Q3 · Calendar Q4 2026 | +3.6% | -0.7% | KB Financial: profit growth offsets margin and regulatory risks |
Latest beats and misses
Who reports nextBeat on EPS
- STRKFY2026 Q3 · October 29, 2026+121.6% EPS-2.7% move
- RKTFY2026 Q3 · October 29, 2026+10.8% EPS+5.0% move
- ILMNFY2026 Q3 · October 29, 2026+19.1% EPS-16.8% move
- STRCFY2026 Q3 · October 29, 2026+121.6% EPS-1.2% move
- WECFY2026 Q3 · October 29, 2026+21.5% EPS+3.7% move
- DVAFY2026 Q3 · October 29, 2026+7.0% EPS-6.8% move
Missed on EPS
- SYKFY2026 Q3 · October 29, 2026-0.8% EPS-5.0% move
- DLR-PJFY2026 Q3 · October 29, 2026-8.4% EPS— move
- DLRFY2026 Q3 · October 29, 2026-8.4% EPS-3.0% move
- MKLFY2026 Q3 · October 28, 2026-2.3% EPS+1.2% move
- KYMRFY2026 Q3 · October 29, 2026-4.8% EPS+0.1% move
- DHIFY2026 Q4 · October 29, 2026-11.3% EPS+2.5% move
Get the EG recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-10-29T17:10:37.981819+00:00
- FN2 earnings calendar · 2026-10-30T01:23:13.979536+00:00
- Polygon adjusted daily market bars · 2026-10-30T13:50:43.411290+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-30T13:50:43.408617+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-30. For educational purposes only; not investment advice.